close
MENU
3 mins to read

R&D boost much needed & long overdue


The budget's $234 million boost to support business research and development is a “clever” investment that is bound to ripen hefty returns.
Brad Duft, president of CoDa Therapeutics, a company operating locally and in the US, told the Natio

Kristina Koveshnikova
Wed, 11 Jul 2018

The budget’s $234 million boost to support business research and development is a “clever” investment that is bound to ripen hefty returns.

Brad Duft, president of CoDa Therapeutics, a company operating locally and in the US, told the National Business Review  that New Zealand has tremendous

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Smartphone Only Annual Subscription

NZ$249.00 / yearly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Subscription

NZ$29.95 / monthly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Kristina Koveshnikova
Wed, 11 Jul 2018
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
R&D boost much needed & long overdue
5460
true